{ "meta": { "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.", "terms": "https://open.fda.gov/terms/", "license": "https://open.fda.gov/license/", "last_updated": "2026-08-21", "results": { "skip": 0, "limit": 1, "total": 1 } }, "results": [ { "submissions": [ { "submission_type": "SUPPL", "submission_number": "17", "submission_status": "AP", "submission_status_date": "20080930", "review_priority": "UNKNOWN", "submission_class_code": "EFFICACY", "submission_class_code_description": "Efficacy", "application_docs": [ { "id": "37240", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021567s017lbl.pdf", "date": "20081003", "type": "Label" }, { "id": "28132", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/021567s017ltr.pdf", "date": "20081002", "type": "Letter" } ] }, { "submission_type": "SUPPL", "submission_number": "31", "submission_status": "AP", "submission_status_date": "20130130", "review_priority": "STANDARD", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "28139", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/021567Orig1s031ltr.pdf", "date": "20130204", "type": "Letter" } ] }, { "submission_type": "SUPPL", "submission_number": "23", "submission_status": "AP", "submission_status_date": "20100426", "review_priority": "UNKNOWN", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "37242", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021567s023lbl.pdf", "date": "20100503", "type": "Label" }, { "id": "5748", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/021567s023ltr.pdf", "date": "20100429", "type": "Letter" } ] }, { "submission_type": "SUPPL", "submission_number": "15", "submission_status": "AP", "submission_status_date": "20080325", "review_priority": "PRIORITY", "submission_class_code": "EFFICACY", "submission_class_code_description": "Efficacy", "application_docs": [ { "id": "37238", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021567s015lbl.pdf", "date": "20080327", "type": "Label" }, { "id": "67190", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/021567a015_Atazanavir_Clinpharm_PREA.pdf", "date": "19000101", "type": "Pediatric Clinical Pharmacology Review" }, { "id": "67191", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/021567s015_Atazanavir_Clinical_PREA.pdf", "date": "19000101", "type": "Pediatric Medical Review" }, { "id": "28131", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/021567s015ltr.pdf", "date": "20080328", "type": "Letter" } ] }, { "submission_type": "SUPPL", "submission_number": "11", "submission_status": "AP", "submission_status_date": "20060809", "review_priority": "STANDARD", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "15785", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021567s008s011lbl.pdf", "date": "20060811", "type": "Label" }, { "id": "28128", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021567s008, 021567s011LTR.pdf", "date": "20060814", "type": "Letter" } ] }, { "submission_type": "SUPPL", "submission_number": "48", "submission_status": "AP", "submission_status_date": "20231107", "review_priority": "STANDARD", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "76524", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021567s048,206352s010lbl.pdf", "date": "20231108", "type": "Label" }, { "id": "76536", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/021567Orig1s048; 206352Orig1s010ltr.pdf", "date": "20231108", "type": "Letter" } ] }, { "submission_type": "SUPPL", "submission_number": "8", "submission_status": "AP", "submission_status_date": "20060809", "review_priority": "STANDARD", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "28127", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021567s008, 021567s011LTR.pdf", "date": "20060814", "type": "Letter" }, { "id": "37235", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021567s008s011lbl.pdf", "date": "20060811", "type": "Label" } ] }, { "submission_type": "SUPPL", "submission_number": "38", "submission_status": "AP", "submission_status_date": "20150924", "review_priority": "PRIORITY", "submission_class_code": "EFFICACY", "submission_class_code_description": "Efficacy", "application_docs": [ { "id": "51248", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/N021567_atazanavir_Orig_WR.pdf", "date": "20110802", "type": "Pediatric Written Request" }, { "id": "51249", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/N021567_atazanavir_Amend_1.pdf", "date": "20030825", "type": "Pediatric Amendment 1" }, { "id": "51250", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/N021567_atazanavir_Reissue_1.pdf", "date": "20061204", "type": "Pediatric Reissue Amendment 1" }, { "id": "51251", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/N021567_atazanavir_Reissue_2.pdf", "date": "20080501", "type": "Pediatric Reissue Amendment 2" }, { "id": "51252", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/N021567_atazanavir_Reissue_3.pdf", "date": "20090429", "type": "Pediatric Reissue Amendment 3" }, { "id": "51253", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/N021567_atazanavir_Reissue_4.pdf", "date": "20111122", "type": "Pediatric Reissue Amendment 4" }, { "id": "51254", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/https://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/DevelopmentResources/UCM452756.pdf", "date": "20130129", "type": "Pediatric Reissue Amendment 5" }, { "id": "51255", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/N021567_atazanavir_Reissue_6.pdf", "date": "20130520", "type": "Pediatric Reissue Amendment 6" }, { "id": "51739", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/206352 atazanavir clinical both.pdf", "date": "19000101", "type": "Pediatric Medical Review" }, { "id": "51746", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/206352 atazanavir clinpharm both.pdf", "date": "19000101", "type": "Pediatric Clinical Pharmacology Review" }, { "id": "51747", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/206352 atazanavir statistical both.pdf", "date": "19000101", "type": "Pediatric Statistical Review" }, { "id": "54094", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/206352Orig1s000, 021567Orig1s035_Atazanavir_Clinical.pdf", "date": "19000101", "type": "Pediatric Medical Review" }, { "id": "54095", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/206352Orig1s000, 021567Orig1s035_Atazanavir_Clinical.pdf", "date": "19000101", "type": "Pediatric Medical Review" }, { "id": "28143", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/206352Orig1s003,021567Orig1s038ltr.pdf", "date": "20150928", "type": "Letter" }, { "id": "37246", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206352s003,021567s038lbl.pdf", "date": "20151210", "type": "Label" } ] }, { "submission_type": "SUPPL", "submission_number": "4", "submission_status": "AP", "submission_status_date": "20041005", "review_priority": "STANDARD", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "37233", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21567s004lbl.pdf", "date": "20041008", "type": "Label" }, { "id": "5745", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/21567s004ltr.pdf", "date": "20041008", "type": "Letter" } ] }, { "submission_type": "SUPPL", "submission_number": "44", "submission_status": "AP", "submission_status_date": "20200924", "review_priority": "STANDARD", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "64680", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/021567Orig1s044; 206352Orig1s008ltr.pdf", "date": "20200925", "type": "Letter" }, { "id": "64688", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021567s044,206352s008lbl.pdf", "date": "20200925", "type": "Label" } ] }, { "submission_type": "SUPPL", "submission_number": "36", "submission_status": "AP", "submission_status_date": "20150226", "review_priority": "UNKNOWN", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "5751", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/021567Orig1s036ltr.pdf", "date": "20150227", "type": "Letter" } ] }, { "submission_type": "SUPPL", "submission_number": "2", "submission_status": "AP", "submission_status_date": "20040706", "review_priority": "UNKNOWN", "submission_class_code": "EFFICACY", "submission_class_code_description": "Efficacy", "application_docs": [ { "id": "5744", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/21567se2-002ltr.pdf", "date": "20040707", "type": "Letter" }, { "id": "15783", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21567se2-002_reyataz_lbl.pdf", "date": "20040707", "type": "Label" } ] }, { "submission_type": "SUPPL", "submission_number": "28", "submission_status": "AP", "submission_status_date": "20120314", "review_priority": "STANDARD", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "15790", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021567s028lbl.pdf", "date": "20120316", "type": "Label" }, { "id": "28138", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/021567s028ltr.pdf", "date": "20120316", "type": "Letter" } ] }, { "submission_type": "SUPPL", "submission_number": "42", "submission_status": "AP", "submission_status_date": "20180418", "review_priority": "STANDARD", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "53740", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021567s042,206352s007lbl.pdf", "date": "20180419", "type": "Label" }, { "id": "53767", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/021567Orig1s042,206352Orig1s007ltr.pdf", "date": "20180420", "type": "Letter" } ] }, { "submission_type": "SUPPL", "submission_number": "34", "submission_status": "AP", "submission_status_date": "20140226", "review_priority": "PRIORITY", "submission_class_code": "MANUF (CMC)", "submission_class_code_description": "Manufacturing (CMC)" }, { "submission_type": "SUPPL", "submission_number": "26", "submission_status": "AP", "submission_status_date": "20111017", "review_priority": "STANDARD", "submission_class_code": "EFFICACY", "submission_class_code_description": "Efficacy", "application_docs": [ { "id": "37243", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021567s026lbl.pdf", "date": "20111017", "type": "Label" }, { "id": "28137", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/021567s026ltr.pdf", "date": "20111019", "type": "Letter" } ] }, { "submission_type": "SUPPL", "submission_number": "40", "submission_status": "AP", "submission_status_date": "20170523", "review_priority": "STANDARD", "submission_class_code": "EFFICACY", "submission_class_code_description": "Efficacy", "application_docs": [ { "id": "48528", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/021567Orig1s040,206352Orig1s005ltr.pdf", "date": "20170525", "type": "Letter" }, { "id": "48542", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021567s040,206352s005lbl.pdf", "date": "20170525", "type": "Label" } ] }, { "submission_type": "SUPPL", "submission_number": "18", "submission_status": "AP", "submission_status_date": "20080220", "review_priority": "STANDARD", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "15787", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021567s018lbl.pdf", "date": "20080225", "type": "Label" }, { "id": "28133", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/021567s018ltr.pdf", "date": "20080222", "type": "Letter" } ] }, { "submission_type": "SUPPL", "submission_number": "32", "submission_status": "AP", "submission_status_date": "20130815", "review_priority": "STANDARD", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "37245", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021567s032s033lbl.pdf", "date": "20130821", "type": "Label" }, { "id": "5750", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/021567Orig1s032,s033ltr.pdf", "date": "20130820", "type": "Letter" } ] }, { "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20030620", "review_priority": "PRIORITY", "submission_class_code": "TYPE 1", "submission_class_code_description": "Type 1 - New Molecular Entity", "application_docs": [ { "id": "37231", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/21567_reyataz_lbl.pdf", "date": "20030708", "type": "Label" }, { "id": "42213", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/021567_reyataz_toc.html", "date": "20030909", "type": "Review" }, { "id": "5742", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21567ltr.pdf", "date": "20030806", "type": "Letter" }, { "id": "63859", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/N021567-atazanavir-written-request.pdf", "date": "19000101", "type": "Pediatric Written Request" }, { "id": "63860", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/N021567-atazanavir-Amend-1.pdf", "date": "19000101", "type": "Pediatric Amendment 1" }, { "id": "63861", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/N021567-atazanavir--reissue-1.pdf", "date": "19000101", "type": "Pediatric Reissue Amendment 1" }, { "id": "63862", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/N021567-atazanavir-reissue-2.pdf", "date": "19000101", "type": "Pediatric Reissue Amendment 2" }, { "id": "63863", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/N021567-atazanavir-reissue-3.pdf", "date": "19000101", "type": "Pediatric Amendment 3" }, { "id": "63864", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/N021567-atazanavir-reissue-4.pdf", "date": "19000101", "type": "Pediatric Amendment 4" }, { "id": "63865", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/N021567-atazanavir-reissue-5.pdf", "date": "19000101", "type": "Pediatric Reissue Amendment 5" }, { "id": "63866", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/N021567-atazanavir-reissue-6.pdf", "date": "19000101", "type": "Pediatric Reissue Amendment 6" } ] }, { "submission_type": "SUPPL", "submission_number": "16", "submission_status": "AP", "submission_status_date": "20080815", "review_priority": "STANDARD", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "5747", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/021567s016ltr.pdf", "date": "20080820", "type": "Letter" }, { "id": "37239", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021567s016lbl.pdf", "date": "20080826", "type": "Label" } ] }, { "submission_type": "SUPPL", "submission_number": "22", "submission_status": "AP", "submission_status_date": "20100122", "review_priority": "STANDARD", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "37241", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021567s022lbl.pdf", "date": "20100124", "type": "Label" }, { "id": "28135", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/021567s022ltr.pdf", "date": "20100128", "type": "Letter" } ] }, { "submission_type": "SUPPL", "submission_number": "14", "submission_status": "AP", "submission_status_date": "20071221", "review_priority": "STANDARD", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "15786", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021567s014lbl.pdf", "date": "20080108", "type": "Label" }, { "id": "28130", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/021567s014ltr.pdf", "date": "20080109", "type": "Letter" } ] }, { "submission_type": "SUPPL", "submission_number": "12", "submission_status": "AP", "submission_status_date": "20070322", "review_priority": "STANDARD", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "37237", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021567s012lbl.pdf", "date": "20070331", "type": "Label" }, { "id": "28129", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/021567s012LTR.pdf", "date": "20070331", "type": "Letter" } ] }, { "submission_type": "SUPPL", "submission_number": "49", "submission_status": "AP", "submission_status_date": "20241205", "review_priority": "STANDARD", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "80530", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/021567Orig1s049;206352Orig1s011ltr.pdf", "date": "20241206", "type": "Letter" }, { "id": "80540", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021567s049,206352s011lbl.pdf", "date": "20241210", "type": "Label" } ] }, { "submission_type": "SUPPL", "submission_number": "9", "submission_status": "AP", "submission_status_date": "20061016", "review_priority": "N/A", "submission_class_code": "MANUF (CMC)", "submission_class_code_description": "Manufacturing (CMC)", "application_docs": [ { "id": "5746", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021567s009ltr.pdf", "date": "20061023", "type": "Letter" }, { "id": "37236", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021567s009lbl.pdf", "date": "20061018", "type": "Label" } ] }, { "submission_type": "SUPPL", "submission_number": "47", "submission_status": "AP", "submission_status_date": "20230414", "review_priority": "N/A", "submission_class_code": "MANUF (CMC)", "submission_class_code_description": "Manufacturing (CMC)", "application_docs": [ { "id": "74201", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/021567Orig1s047ltr.pdf", "date": "20230510", "type": "Letter" } ] }, { "submission_type": "SUPPL", "submission_number": "7", "submission_status": "AP", "submission_status_date": "20060125", "review_priority": "STANDARD", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "37234", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021567s007lbl.pdf", "date": "20060125", "type": "Label" }, { "id": "28126", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021567s007ltr.pdf", "date": "20060130", "type": "Letter" } ] }, { "submission_type": "SUPPL", "submission_number": "39", "submission_status": "AP", "submission_status_date": "20160915", "review_priority": "901 REQUIRED", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "45307", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021567s039,206352s004lbl.pdf", "date": "20160915", "type": "Label" }, { "id": "45337", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/021567Orig1s039,206352Orig1s004ltr.pdf", "date": "20160920", "type": "Letter" } ] }, { "submission_type": "SUPPL", "submission_number": "5", "submission_status": "AP", "submission_status_date": "20050718", "review_priority": "STANDARD", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "15784", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021567s005lbl.pdf", "date": "20050721", "type": "Label" }, { "id": "28125", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/021567s005ltr.pdf", "date": "20050721", "type": "Letter" } ] }, { "submission_type": "SUPPL", "submission_number": "37", "submission_status": "AP", "submission_status_date": "20150327", "review_priority": "901 REQUIRED", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "15793", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021567s037,206352s002lbl.pdf", "date": "20150402", "type": "Label" }, { "id": "28142", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/021567Orig1s037,206352Orig1s002ltr.pdf", "date": "20150401", "type": "Letter" } ] }, { "submission_type": "SUPPL", "submission_number": "35", "submission_status": "AP", "submission_status_date": "20140602", "review_priority": "PRIORITY", "submission_class_code": "EFFICACY", "submission_class_code_description": "Efficacy", "application_docs": [ { "id": "51738", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/206352Orig1s000,021567Orig1s035_Atazanavir_Clinical.pdf", "date": "19000101", "type": "Pediatric Medical Review" }, { "id": "51743", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/206352Orig1s000, 021567Orig1s035_Atazanavir_Statistical.pdf", "date": "19000101", "type": "Pediatric Statistical Review" }, { "id": "15792", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206352s000,021567s035lbl.pdf", "date": "20140603", "type": "Label" }, { "id": "21737", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/206352Orig1s000_021567Orig1s035TOC.html", "date": "20150407", "type": "Review" }, { "id": "24206", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/206352Orig1s000_021567Orig1s035SumR.pdf", "date": "20150407", "type": "Summary Review" }, { "id": "28141", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/206352Orig1s000,21567Orig1s035ltr.pdf", "date": "20140603", "type": "Letter" } ] }, { "submission_type": "SUPPL", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20040316", "review_priority": "STANDARD", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "5743", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/21567slr001ltr.pdf", "date": "20040319", "type": "Letter" }, { "id": "37232", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21567slr001_reyataz_lbl.pdf", "date": "20040405", "type": "Label" } ] }, { "submission_type": "SUPPL", "submission_number": "27", "submission_status": "AP", "submission_status_date": "20120217", "review_priority": "901 REQUIRED", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "5749", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/021567s027ltr.pdf", "date": "20120223", "type": "Letter" }, { "id": "37244", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021567s027lbl.pdf", "date": "20120224", "type": "Label" } ] }, { "submission_type": "SUPPL", "submission_number": "41", "submission_status": "AP", "submission_status_date": "20171020", "review_priority": "STANDARD", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "50140", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/021567Orig1s041,206352Orig1s006ltr.pdf", "date": "20171023", "type": "Letter" }, { "id": "50165", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021567s041,206352s006lbl.pdf", "date": "20171024", "type": "Label" } ] }, { "submission_type": "SUPPL", "submission_number": "19", "submission_status": "AP", "submission_status_date": "20091105", "review_priority": "STANDARD", "submission_class_code": "EFFICACY", "submission_class_code_description": "Efficacy", "application_docs": [ { "id": "15788", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021567s019lbl.pdf", "date": "20091123", "type": "Label" }, { "id": "21736", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/021567Orig1s019.pdf", "date": "20140805", "type": "Review" }, { "id": "28134", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/021567s019ltr.pdf", "date": "20100125", "type": "Letter" } ] }, { "submission_type": "SUPPL", "submission_number": "33", "submission_status": "AP", "submission_status_date": "20130815", "review_priority": "STANDARD", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "15791", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021567s032s033lbl.pdf", "date": "20130821", "type": "Label" }, { "id": "28140", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/021567Orig1s032,s033ltr.pdf", "date": "20130820", "type": "Letter" } ] }, { "submission_type": "SUPPL", "submission_number": "25", "submission_status": "AP", "submission_status_date": "20110204", "review_priority": "PRIORITY", "submission_class_code": "EFFICACY", "submission_class_code_description": "Efficacy", "application_docs": [ { "id": "42214", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/021567Orig1s025.pdf", "date": "20150720", "type": "Review" }, { "id": "15789", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021567s025lbl.pdf", "date": "20110209", "type": "Label" }, { "id": "28136", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/021567s025ltr.pdf", "date": "20110210", "type": "Letter" } ] } ], "application_number": "NDA021567", "sponsor_name": "BRISTOL MYERS SQUIBB", "openfda": { "application_number": [ "NDA021567" ], "brand_name": [ "REYATAZ" ], "generic_name": [ "ATAZANAVIR" ], "manufacturer_name": [ "E.R. Squibb & Sons, L.L.C." ], "product_ndc": [ "0003-3622", "0003-3624", "0003-3631", "0003-3638" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "ATAZANAVIR SULFATE" ], "rxcui": [ "402093", "402094", "402246", "402247", "664741", "664743", "1598985", "1598989" ], "spl_id": [ "510c2d51-4943-401c-a008-ea22f61c6938" ], "spl_set_id": [ "165cff62-b284-4a27-a65d-9ec8a5bfcdd8" ], "package_ndc": [ "0003-3624-12", "0003-3631-12", "0003-3622-12", "0003-3638-10" ], "unii": [ "4MT4VIE29P" ] }, "products": [ { "product_number": "003", "reference_drug": "Yes", "brand_name": "REYATAZ", "active_ingredients": [ { "name": "ATAZANAVIR SULFATE", "strength": "EQ 200MG BASE" } ], "reference_standard": "No", "dosage_form": "CAPSULE", "route": "ORAL", "marketing_status": "Prescription", "te_code": "AB" }, { "product_number": "001", "reference_drug": "Yes", "brand_name": "REYATAZ", "active_ingredients": [ { "name": "ATAZANAVIR SULFATE", "strength": "EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**" } ], "reference_standard": "No", "dosage_form": "CAPSULE", "route": "ORAL", "marketing_status": "Discontinued" }, { "product_number": "004", "reference_drug": "Yes", "brand_name": "REYATAZ", "active_ingredients": [ { "name": "ATAZANAVIR SULFATE", "strength": "EQ 300MG BASE" } ], "reference_standard": "Yes", "dosage_form": "CAPSULE", "route": "ORAL", "marketing_status": "Prescription", "te_code": "AB" }, { "product_number": "002", "reference_drug": "Yes", "brand_name": "REYATAZ", "active_ingredients": [ { "name": "ATAZANAVIR SULFATE", "strength": "EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**" } ], "reference_standard": "No", "dosage_form": "CAPSULE", "route": "ORAL", "marketing_status": "Discontinued" } ] } ] }